首页> 美国卫生研究院文献>Radiation Oncology (London England) >BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

【2h】

BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

机译：BRCC3用作放射治疗的鼻咽癌患者的预后标志物并在体外介导放射抵抗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundBRCC3 has been found to be aberrantly expressed in breast tumors and involved in DNA damage response. The contribution of BRCC3 to nasopharyngeal carcinoma prognosis and radiosensitivity is still unclear.

机译：背景已发现BRCC3在乳腺肿瘤中异常表达并参与DNA损伤反应。 BRCC3对鼻咽癌预后和放射敏感性的贡献尚不清楚。

著录项

期刊名称 Radiation Oncology (London England)
作者
Ziwei Tu; Bingqing Xu; Chen Qu; Yalan Tao; Chen Chen; Wenfeng Hua; Guokai Feng; Hui Chang; Zhigang Liu; Guo Li; Changbin Jiang; Wei Yi; Musheng Zeng; Yunfei Xia;
展开▼
作者单位

展开▼
年(卷),期 2015(10),-1
年度 2015
页码 123
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;放射医学;影像诊断学;
关键词
BRCC3 Nasopharyngeal carcinoma Prognostic marker Radioresistance;

机译：BRCC3;鼻咽癌;预后指标;放射抵抗;

相似文献

外文文献
中文文献
专利

1. 接受调强放射治疗的鼻咽癌患者治疗后随访期血浆Epstein-Barr病毒DNA水平的预后价值 [J] . Wen-Fei Li, Jun Ma, Yuan Zhang, 癌症（英文版） . 2018,第008期
2. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro [J] . Ziwei Tu, Bingqing Xu, Chen Qu, Radiation oncology . 2015,第1期

机译：BRCC3可作为放射治疗的鼻咽癌患者的预后标志物，并在体外介导抗辐射能力
3. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro [J] . Ziwei Tu, Bingqing Xu, Chen Qu, Radiation oncology . 2015,第1期

机译：BRCC3可作为放射治疗的鼻咽癌患者的预后标志物，并在体外介导抗辐射能力
4. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro [J] . Ziwei Tu, Bingqing Xu, Chen Qu, Radiation oncology . 2015,第1期

机译：BRCC3可作为放射治疗的鼻咽癌患者的预后标志物，并在体外介导抗辐射能力
5. Matrix Metalloproteinase-2 and High Vascular Endothelial Growth Factor as Prognostic Markers for Intrahepatic Tumor Recurrence in Hepatocellular Carcinoma Patients Receiving Radiotherapy [C] . Eun-Jung Lee, Jinsil Seong, Yang-Gun Suh, Molecular Medicine TRI-CON. . 2014

机译：基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物，接受放射治疗
6. Extracranial carotid stenosis in nasopharyngeal carcinoma post radiotherapy: An under-detected problem. [D] . Lam, Wai Man Wynnie. 2003

机译：放射治疗后鼻咽癌的颅外颈动脉狭窄：一个未被发现的问题。
7. Prognostic Factors and Survival in Patients with Radiation-Related Second Malignant Neoplasms Following Radiotherapy for Nasopharyngeal Carcinoma [O] . Mian Xi, Shi-Liang Liu, Lei Zhao, -1

机译：鼻咽癌放疗后与放射相关的第二恶性肿瘤患者的预后因素和生存
8. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro [O] . Ziwei Tu, Bingqing Xu, Chen Qu, 2015

机译：BRCC3用作放射治疗的鼻咽癌患者的预后标志物，并在体外介导放射抵抗

BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

摘要

著录项

相似文献

相关主题

期刊订阅